BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Scott will join a panel discussion focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
News | 05. 14. 2012
Scott will sit on a panel focusing on raising US venture capital at the BioFinance 2012 conference in Toronto on May 29-30, 2012
